Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7797]

'Avatars' reveal new genetic sources of drug response in late-stage colorectal therapy

'Avatars' reveal new genetic sources of drug response in late-stage colorectal therapy

Attacking acute myeloid leukemia

Attacking acute myeloid leukemia

Investigational therapeutic KW-0761 efficiently depletes immune system–suppressing Treg cells

Investigational therapeutic KW-0761 efficiently depletes immune system–suppressing Treg cells

ECC 2015: A cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination

ECC 2015: A cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination

ECC 2015:  First ‘targeted’ treatment for small cell lung cancer shows promise

ECC 2015:  First ‘targeted’ treatment for small cell lung cancer shows promise

ECC 2015: Drug combination improves progression-free survival in melanoma patients regardless of genetic status, age and spread of disease

ECC 2015: Drug combination improves progression-free survival in melanoma patients regardless of genetic status...

ECC 2015: Nivolumab improves the proportion of lung cancer patients alive after more than a year

ECC 2015: Nivolumab improves the proportion of lung cancer patients alive after more than a year

ECC 2015: Post diagnosis aspirin improves survival in all gastrointestinal cancers

ECC 2015: Post diagnosis aspirin improves survival in all gastrointestinal cancers

ECC 2015:  A combination of two targeted therapies results in melanoma patients living significantly longer: new results

ECC 2015:  A combination of two targeted therapies results in melanoma patients living significantly longer: new...

$ECC 2015: Atezolizumab set to change refractory lung cancer treatment$

ECC 2015: Atezolizumab set to change refractory lung cancer treatment

More from ecancer